Rotigotine transdermal patches (Neupro) for the treatment of Parkinson's disease.

The main clinical features of Parkinson’s disease are tremor, muscular rigidity, akinesia (inability to move), and postural instability. Other features of the disease include changes in gait, mask-like face, micrographia (progressively smaller handwriting), and psychiatric symptoms; depression occurs in 50% of patients over the course of their illness. The diagnosis is made by clinical symptoms and the patient’s response to antiparkinsonian drug treatment.